1.
Tetanus vaccines: WHO position paper, February 2017 – Recommendations
by World Health Organization
Vaccine, 2017, Vol.36 (25), p.3573-3575
2.
Maternal and neonatal tetanus
by Thwaites, C Louise, Dr
The Lancet (British edition), 2015, Vol.385 (9965), p.362-370
3.
Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017
by Khetsuriani, Nino
Vaccine, 2022-03-15, Vol.40 (12), p.1810-1820
4.
Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women
by Fortner, Kimberly B
Vaccine, 2018-10-08, Vol.36 (42), p.6354-6360
5.
6.
Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate
by Yu, Yun-Zhou
Vaccine, 2011, Vol.29 (35), p.5978-5985
8.
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pert...
by Marlow, Robin
Vaccine, 2018-04-19, Vol.36 (17), p.2300-2306
9.
High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study
by Steens, Anneke
Vaccine, 2010, Vol.28 (49), p.7803-7809
10.
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertuss...
by Brandon, Donald
Vaccine, 2018-10-08, Vol.36 (42), p.6325-6333
11.
Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand
by Suntarattiwong, Piyarat
Vaccine, 2020-02-24, Vol.38 (9), p.2128-2131
13.
Seroprevalence of anti-tetanus antibodies in mothers and cord blood and associated factors in health-care settings in Lao People’s Democratic Republic
by Ounnavong, Phoumsavath
Vaccine, 2020-01-29, Vol.38 (5), p.1234-1240
14.
15.
A DTaP-IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years' clinical experience
by Plotkin, Stanley A
Expert review of vaccines, 2011-07-01, Vol.10 (7), p.981-1005
16.
17.
Demand- and supply-side determinants of diphtheria-pertussis-tetanus nonvaccination and dropout in rural India
by Ghosh, Arpita
Vaccine, 2017, Vol.35 (7), p.1087-1093
18.
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice
by Tierney, Rob
Vaccine, 2012, Vol.30 (20), p.3047-3052
19.
Cost-effectiveness of adult vaccinations: A systematic review
by Leidner, Andrew J
Vaccine, 2019-01-07, Vol.37 (2), p.226-234
20.
Immunogenicity of the reduced-antigen-content dTpa vaccine ( Boostrix® ) in adults 55 years of age and over: A sub-analysis of four trials
by Van Damme, Pierre
Vaccine, 2011, Vol.29 (35), p.5932-5939
